Skip to main
DD

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours, Inc. has demonstrated robust performance in its Healthcare & Water business, with organic sales growth driven by strong demand in medical packaging and biopharma applications. The company is experiencing a positive shift towards new products, supported by a current vitality index of approximately 35% and an ambitious goal of 45%, which is expected to enhance its pricing and mix over the coming years. Additionally, DuPont's Electronics & Industrial segment shows promise for volume growth, fueled by advancements in 5G technology and the Internet of Things (IoT), contributing to an optimistic outlook for the company's future valuation.

Bears say

The financial analyst notes significant concerns regarding DuPont de Nemours's stock, primarily due to expected delays in synergy realization following the company's restructuring and its continued exposure to the underperforming electronics and construction markets. Furthermore, the slow recovery in China raises additional uncertainties about future revenue growth and profitability, as these sectors are vital to DuPont's overall performance. This combination of factors contributes to a negative outlook, underscoring the challenges the company faces in generating anticipated profits from its key focus areas, particularly healthcare and water.

DD has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 11 analysts, DD has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.